More than 90% of employers agreed a rebate-free approach is easier to understand and would improve drug price transparency, according to the survey conducted for Evernorth, which operates a pharmacy benefit manager.
An article from
Dive Brief
More than 90% of employers agreed a rebate-free approach is easier to understand and would improve drug price transparency, according to the survey conducted for Evernorth.
Published May 13, 2026
Medications are stored on shelves at a pharmacy on May 12, 2025, in Los Angeles, Calif. Eighty-six percent of employers said a model without rebates would improve the predictability of pharmacy spending, a survey showed.
Optum Rx unveils pharmacy model with clear fees, building on transparency push
Bipartisan lawmakers reintroduce bill barring PBMs from owning pharmacies
FDA floats possible approach to repurpose approved drugs under new uses
To gain tariff exemptions, drugmakers must reveal US production plans
New payer-backed ad campaign pushes for No Surprises Act IDR reform
Nearly 80% of payers prefer vendor-built AI solutions, survey finds
Doctors Skeptical of Insurers' Pledges to Rein in Prior Authorization
Medicare is spending far less than expected on new Alzheimer’s drugs
Drugmakers have to go through rigorous tests to get a lower tariff rate
Amgen expands crackdown on what it says is misuse of 340B program
